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Abstract
Purpose of review Small-bore chest tubes are widely used in
the management of common pleural disease. Guidelines sug-
gest that patients with malignant pleural effusions, pneumo-
thorax and pleural infection may be successfully managed
with small-bore drains. However, good quality data is often
lacking. This article reviews the evidence for the treatment
efficacy and potential adverse effects of different chest tube
sizes.
Recent findings In a large randomised study, the small differ-
ence in pain scores between large and small drains was not
clinically significant. However, small-bore chest tubes com-
monly suffer from blockage or inadvertent removal, and may
not be as effective in providing successful pleurodesis for
malignant pleural effusions.
Summary Although they may be effective in managing pleu-
ral infection, and less painful than large drains, small bore
drains may be less effective for pleurodesis.
Keywords Chest drain . Small bore . Size . Pleural .
Effusion . Pneumothorax . Pleural Infection
Introduction
The optimal size of chest tube for management of pleural
diseases is not known. Management of malignant pleural ef-
fusions traditionally relies on chest tube insertion, drainage of
fluid and subsequent talc pleurodesis. The British Thoracic
Society (BTS) guidelines [1] advocates the use of smaller
tubes (<16 French [F]). The evidence for smaller tubes is
based upon case series [1] and three comparative studies
[2–4], of which only one small study was randomised [4].
Patients who are symptomatic with a large spontaneous
pneumothorax often require chest tube insertion, after
attempted aspiration in primary spontaneous pneumothorax.
Guidelines suggest that, in clinically stable patients, small-
bore (≤14 F) chest drains are sufficient [1, 5]. The manage-
ment of pleural infection requires drainage of the infected
fluid. Traditionally, larger bore chest tubes have been used to
drain pus or viscid fluid. However, small-bore chest drains are
often the first line of choice of radiologists and respiratory
physicians and may be sufficient in many cases. This article
will review the evidence for the treatment efficacy and poten-
tial adverse effects of different chest tube sizes for these
indications.
Efficacy
Pleurodesis for Malignant Pleural Effusion
The most commonly used agent for pleurodesis to prevent
fluid recurrence in malignant pleural effusions in the USA
and Europe is sterile graded talc. At present, standard practice
for talc pleurodesis involves instillation of talc slurry via chest
tube (once the pleural fluid has been drained). Success rates
for talc pleurodesis are quoted in the BTS guidelines as
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between 60 and 90% [1]. The same guidelines advocate the
use of small-bore chest tubes. However, 7 of the 15 studies
cited in the guidelines used large-bore (20–28 F) chest tubes as
was historically often used [1]. The evidence for efficacy in
small-bore tubes comes from case series, two retrospective
comparative studies [2, 3] and only one small randomised
study of 18 patients which was a feasibility study, not de-
signed to compare efficacy [4].
The recently published TIME1 (1st Therapeutic
Interventions in Malignant Effusion) randomised controlled
trial (RCT) assessed the effect of chest tube size and analgesia
(NSAIDs vs opiates) on pain and clinical efficacy related to
pleurodesis in patients with malignant pleural effusion [6••].
Designed as a non-inferiority study (with a margin of 15%),
the authors found that 12 F chest tubes were associated with
higher pleurodesis failure rate than 24 F tubes (30 vs 24%),
thereby failing to meet non-inferiority criteria (difference,
−6%; one-sided 95%CI, −20% to ∞; p=0.14). However, a
large number (206) of the patients recruited in the study had
undergone a thoracoscopy (in which a large-bore drain is al-
ways placed) and so could not be included in the primary
comparison for pleurodesis efficacy by drain size.
Nevertheless, the 100 patients included in this analysis still
represent the largest study to address this question, from
which we cannot conclude equivalence between small- and
large-bore drains.
An alternative approach to talc pleurodesis is the poudrage
(or insufflation) of talc powder at thoracoscopy. A Cochrane
review (2004) found that talc poudrage at thoracoscopy to
have an improved relative risk or non-recurrence (1.19) com-
pared to talc slurry [7]. However, a later RCTsuggested only a
trend towards superiority of talc poudrage and only in a sub-
group analysis (excluding those patients with trapped lung)
did the authors find a statistically significant difference [8].
Another large non-randomised prospective study found fewer
pleurodesis failures in the talc poudrage group. As a result of
these conflicting data, an RCT to directly compare talc
poudrage to talc slurry for pleurodesis efficacy is currently
recruiting in the UK [9]. Although designed to directly com-
pare poudrage vs slurry, this ongoing study may be hampered
in its conclusions by the result of the TIME1 study [6••] as the
patients in the post-thoracoscopy arm will have large-bore
chest drains and those receiving slurry small-bore drains,
which may not be as effective as per the TIME1 result.
Pneumothorax
Patients who are symptomatic with large spontaneous pneu-
mothorax often require chest tube insertion. The BTS and the
Belgian Society of Pneumology Guidelines suggest attempted
needle aspiration first, followed by chest drain if the lung has
failed to sufficiently reinflate [1, 10]. The American College
of Chest Physicians (ACCP) guidelines advise initial
treatment with chest tube, although these may now be out of
date (2001) [5]. All guidelines suggest that in clinically stable
patients, small-bore (≤14 F) chest drain are sufficient [1, 5,
10]. There exists no randomised trial data. The majority of the
evidence for these guidelines comes from multiple case series
[11]. One small retrospective comparative study found no dif-
ference in treatment success between large-bore (20 F) and
small-bore (9 F) chest drain [12].
Failure of treatment of spontaneous pneumothorax is typi-
cally defined as the need for further procedure (i.e., another
chest tube) or surgical intervention, if the lung fails to re-
expand or there is persistent air leak. Suction delivered via
high-volume low-pressure system can be employed in such
patients. Some physicians may also advocate replacing a
small-bore tube with a large-bore one to allow a greater total
flow rate of air—as flow rate is proportional to the fifth power
of the radius of the tube (Fanning equation). The theory in
both cases is that the air can be removed from the pleural
cavity at a rate exceeding the egress of air through the breach
in the visceral pleura, thereby reinflating the lung. This theory
would seem rational if there is clear evidence of insufficient
drainage of air (i.e., subcutaneous emphysema, increasing
pneumothorax size, or worsening clinical condition).
However, there is no good trial evidence to support the use
of larger drains or suction in stable patients with a continuing
air leak. The idea that the “healing” of the visceral air leakmay
be promoted by apposition of the visceral and parietal pleural
layers has not been proven.
A large-bore chest tube (>28 F) is often recommended in
the management of traumatic pneumothorax given the poten-
tial need of air and/or blood evacuation. However, this is
based upon expert opinion [13] and a recent small RCT, in
fact, found that for simple, uncomplicated traumatic pneumo-
thorax, use of a small chest tube (14 F) was associated with
reduced pain at insertion and no other clinically important
differences (such as drain duration or success rate) [14•].
Pleural Infection
Pleural infection carries a high mortality and 15% large pro-
portion of patients will require surgical intervention [15].
Effective management of pleural infection requires drainage
of the infected fluid. Traditionally, larger bore chest tubes have
been used to drain pus or viscid fluid. However, numerous
case series have reported successful treatment with small-
bore chest drains which are often the first line choice of radi-
ologists and respiratory physicians. A largest prospective RCT
of pleural infection included 405 patients treated with a range
of chest tube sizes [15]. Patients were randomised to intra-
pleural fibrinolytics or placebo, rather than small (≤14 F) or
larger chest tube, but clinical outcomes, pain, and adverse
events could be analysed by chest tube size [16]. The authors
found no significant difference in the frequency with which
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patients either died or required thoracic surgery between
groups with chest tubes of varying sizes (<10 F, number dying
or needing surgery 21/58 (36%); size 10–14 F, 75/208 (36%);
size 15–20 F, 28/70 (40%); size >20 F, 30/69 (44%); p=0.27).
It was concluded that smaller chest tubes could be as effective
as large bore and may therefore be the initial treatment of
choice for pleural infection. A subsequent randomised study
of pleural infection found improved fluid drainage and re-
duced the frequency of surgical referral in the patients receiv-
ing tissue plasminogen activator and DNase (compared to
placebo). The majority of these patients were managed with
small-bore drains (<15 F) [17].
Adverse Events
The complication rate for chest drain insertion is regularly
retrospectively collected as part of the BTS Pleural
Procedures Audit. The 2015 audit included 1394 episodes of
chest drain insertion, the majority of which (88%) were small
bore (<16 F) [18•]. Complications were categorised as imme-
diate or delayed. Immediate complications were failure to
place the drain in the pleural space (2.0%), haemothorax
(iatrogenic) 1.3%, pain (8%), hypotension (1.9%) and organ
puncture (0.6%). Delayed complications were pain (15.6%),
drain falling out (9.2%), drain blockage (8.2%), subcutaneous
emphysema (4.2%), pleural infection (0.4%), skin infection
(1%), re-expansion pulmonary oedema (0.6%) and death
(0.1%). A retrospective review of 100 consecutive patients
who underwent small-bore chest tube placement found that
complications occur less frequently if the drain is placed by
expert operators or under radiological/ultrasonographic guid-
ance [19]. Use of ultrasound in chest drain insertion of pleural
fluid is now mandatory, but only 70% of chest drains and
pleural aspirations were performed using ultrasound guidance
in the recent BTS audit [18•].
Pain
Two randomised studies have suggested that large-bore chest
tubes may be associated with greater pain. The first was a
small (18 patients) feasibility study in patients undergoing
tetracycline pleurodesis [4]. The second was a larger (100
patients) study of patients post-thoracic surgery which com-
pared “small” (19 F) drains with standard larger drains (28–
32 F) [20].
Analysis of the pain scores in 128 patients in the MIST1
study of pleural infection also found that large bore tubes
caused more pain, which was statistically and clinically sig-
nificant. During chest tube insertion and while the tube was in
place, 22/41 (54%) of patients with large bore tube (≥15 F)
described moderate/severe pain, compared with only 21/77
(27%) of patients treated with small tube (<15 F) (p=0.005)
[16]. The authors conclude that “27% of patients with larger-
size tubes experienced moderate to severe pain that might
have been avoided by use of small-size-tubes”.
The larger TIME1 study was undertaken to directly assess
pain as a co-primary outcome by chest tube size and analgesia
type for malignant effusions [6••]. Data from 300 patients
found a statistically significant difference in pain scores be-
tween smaller and larger tubes. However, this, on average,
was small (6 mm) and was below the published minimum
clinically significant threshold for a 100 mm VAS pain score
(13 mm; 95%CI, 10–16 mm) [21]. This difference was con-
sistent even when accounting for rescue analgesia usage.
Therefore, there would appear to be relatively little clinical
benefit in terms of less pain from the use of smaller chest tubes
for malignant pleural effusion pleurodesis.
Complications Post-insertion
Small-bore chest tubes appear to be at greater risk of blockage,
kinking, or inadvertent removal. Older data suggested a block-
age rate of small-bore tubes of 8.1% compared to 5.2% for
large-bore tubes in a prospective (non-randomised) study [22].
Recent data suggests a non-significant increase in rate of com-
plications during tube insertion in the small (12 F) group com-
pared to 24 F group (25 vs 14%, p=0.20) and a higher rate of
unintentional displacement of the tube (42 vs 28%) [6••].
Analysis of chest tubes used to treat found a trend towards
an increased rate of unplanned chest tube displacement in the
smaller tubes (<10 F, 19%; 10–14 F, 23%; size 15–20 F, 0%;
>20 F, 17%), but this did not reach statistical significance
(p=0.18) [16]. The complication rates in data collected pro-
spectively in RCTs are higher than those reported in the ret-
rospective BTS audit.
Conclusion
Guidelines suggest that patients with pneumothorax requiring
chest tube insertion should bemanaged with small (rather than
large) bore tubes. However, there is a dearth of evidence to
support this. Non-RCT data suggests that pleural infection
may be successfully initially managed with small bore drains.
However, it is now unclear whether small bore chest tubes are
as effective as larger drains for pleurodesis for malignant ef-
fusions. Large-bore tubes are often regarded being more pain-
ful, but recent RCT data now suggested that the small differ-
ence in pain scores are not clinical significant in patients with
malignant effusion.
Complications in small-bore chest tubes (blockage or inad-
vertent removal) are higher than larger tubes, and may account
for some of the reduced rate of successful pleurodesis. This
may be an inherent disadvantage of smaller tubes. Use of
small-bore chest tubes in the management of common pleural
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disease is ubiquitous [18•]. Discerning physicians will need to
decide whether to alter their practice with regards to the opti-
mal chest tube size for pleurodesis success.
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